UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints

Molecular cancer research, 2015-01, Vol.13 (1), p.16-28

2015

Volltextzugriff (PDF)

p53 Basic C Terminus Regulates p53 Functions through DNA Binding Modulation of Subset of Target Genes

The Journal of biological chemistry, 2012-06, Vol.287 (26), p.22397-22407

2012

Volltextzugriff (PDF)

Freeing Time and Reducing Costs: The Value of a Specialized Nursing Service in IBD

Inflammatory bowel diseases, 2024-06, Vol.30 (6), p.1046

2024

Volltextzugriff (PDF)

Predictors of Perianal Fistula Relapse in Crohn’s Disease

Inflammatory bowel diseases, 2020-06, Vol.26 (6), p.932-933

Lukin, Dana J

2020

Volltextzugriff (PDF)

Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Clinical gastroenterology and hepatology, 2022-03, Vol.20 (3), p.e361-e379

2022

Volltextzugriff (PDF)

PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn’s Disease

Digestive diseases and sciences, 2023-08, Vol.68 (8), p.3211-3212

2023

Volltextzugriff (PDF)

Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2021-02, Vol.160 (3), p.e3-e5

2021

Volltextzugriff (PDF)

COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study

Therapeutic advances in gastroenterology, 2022, Vol.15, p.175628482211323-17562848221132363

2022

Volltextzugriff (PDF)

Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance

Inflammatory bowel diseases, 2021-05, Vol.27 (6), p.787-790

2021

Volltextzugriff (PDF)

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2020-10, Vol.159 (4), p.1541-1544.e2

2020

Volltextzugriff (PDF)

Article Topic: Positioning Ulcerative Colitis Therapies in 2022 and Beyond

Current gastroenterology reports, 2022-12, Vol.24 (12), p.157-170

2022

Volltextzugriff (PDF)

Incident heart failure is a predictor of adverse outcomes in inflammatory bowel disease

European journal of gastroenterology & hepatology, 2020-02, Vol.32 (2), p.205-215

2020

Volltextzugriff (PDF)

Long-lived intestinal tuft cells serve as colon cancer-initiating cells

The Journal of clinical investigation, 2014-03, Vol.124 (3), p.1283-1295

2014

Volltextzugriff (PDF)

Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications

Digestive diseases and sciences, 2021-06, Vol.66 (6), p.2005-2013

2021

Volltextzugriff (PDF)

Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination

Clinical gastroenterology and hepatology, 2022-06, Vol.20 (6), p.e1493-e1499

2022

Volltextzugriff (PDF)

Shifting the Inflammatory Balance in Ulcerative Colitis Through Diet: A Mediterranean Diet Pattern is Associated with Improvements in Dysbiosis and Disease Activity

Journal of Crohn's and colitis, 2023-11, Vol.17 (10), p.1555-1556

2023

Volltextzugriff (PDF)

Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach

Journal of gastroenterology and hepatology, 2023-02, Vol.38 (2), p.241-250

2023

Volltextzugriff (PDF)

Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn’s disease: the debate continues

Translational gastroenterology and hepatology, 2023-07, Vol.8, p.28-28

2023

Volltextzugriff (PDF)

No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD

Clinical gastroenterology and hepatology, 2021-11, Vol.19 (11), p.2312-2314.e3

2021

Volltextzugriff (PDF)

Helicobacter pylori is associated with increased risk of serrated colonic polyps: Analysis of serrated polyp risk factors

Indian journal of gastroenterology, 2018-05, Vol.37 (3), p.235-242

2018

Volltextzugriff (PDF)

S927 Serum Biologic Levels for Achieving Endoscopic, Biomarker, and Clinical Remission in Post-Operative Crohn’s Disease

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S439-S440

2021

Volltextzugriff (PDF)

S2428 An Unexpected Companion: A Case of Stricturing Crohn’s Disease Ileitis With Severe Histoplasmosis

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1028-S1028

2021

Volltextzugriff (PDF)

The Impact of Delay in Clostridium difficile Testing on Outcomes in Hospitalized IBD Patients With Gastrointestinal Symptoms: 672

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S379-S380

2018

Volltextzugriff (PDF)

The Impact of Substance Abuse on Outcomes in Inflammatory Bowel Disease: 731

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S408-S410

2018

Volltextzugriff (PDF)

Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure

Clinical gastroenterology and hepatology, 2024-03, Vol.22 (10), p.2096-2106

2024

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Englisch
(145)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(45)
Gastroenterology & Hepatology
(37)
Humans
(33)
Gastroenterology
(19)
Female
(18)
Inflammatory Bowel Disease
(18)
Male
(17)
Gastroenterology And Hepatology
(14)
Middle Aged
(14)
Adult
(13)
Retrospective Studies
(13)
Crohn Disease - Drug Therapy
(12)
Treatment Outcome
(11)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(10)
Gastrointestinal Agents - Therapeutic Use
(9)
Remission
(9)
Ulcerative Colitis
(9)
Crohns Disease
(8)
Endoscopy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints

p53 Basic C Terminus Regulates p53 Functions through DNA Binding Modulation of Subset of Target Genes

Freeing Time and Reducing Costs: The Value of a Specialized Nursing Service in IBD

Predictors of Perianal Fistula Relapse in Crohn’s Disease

Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

PRO Tips: First-Rate Guidance for Second-Line Therapy After Tumor Necrosis Factor-Alpha Exposure in Patients with Crohn’s Disease

Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease

COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study

Finding a Needle in the Haystack? Defining the Role of Random Biopsies in IBD Dysplasia Surveillance

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease

Article Topic: Positioning Ulcerative Colitis Therapies in 2022 and Beyond

Incident heart failure is a predictor of adverse outcomes in inflammatory bowel disease

Long-lived intestinal tuft cells serve as colon cancer-initiating cells

Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications

Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS-CoV-2 Vaccination

Shifting the Inflammatory Balance in Ulcerative Colitis Through Diet: A Mediterranean Diet Pattern is Associated with Improvements in Dysbiosis and Disease Activity

Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach

Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn’s disease: the debate continues

No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD

Helicobacter pylori is associated with increased risk of serrated colonic polyps: Analysis of serrated polyp risk factors

S927 Serum Biologic Levels for Achieving Endoscopic, Biomarker, and Clinical Remission in Post-Operative Crohn’s Disease

S2428 An Unexpected Companion: A Case of Stricturing Crohn’s Disease Ileitis With Severe Histoplasmosis

The Impact of Delay in Clostridium difficile Testing on Outcomes in Hospitalized IBD Patients With Gastrointestinal Symptoms: 672

The Impact of Substance Abuse on Outcomes in Inflammatory Bowel Disease: 731

Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure

Suchergebnisse filtern